Skip to main content
logo
TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
2.080
+0.080 (4.00%)
At close: Jul 15, 2025, 4:00 PM
2.010
-0.070 (-3.37%)
After-hours: Jul 15, 2025, 4:04 PM EDT

TELA Bio Revenue

TELA Bio had revenue of $18.52M in the quarter ending March 31, 2025, with 11.55% growth. This brings the company's revenue in the last twelve months to $71.22M, up 12.78% year-over-year. In the year 2024, TELA Bio had annual revenue of $69.30M with 18.56% growth.

Revenue (ttm)
$71.22M
Revenue Growth
+12.78%
P/S Ratio
0.95
Revenue / Employee
$340,751
Employees
209
Market Cap
82.27M

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 69.30M 10.85M 18.56%
Dec 31, 2023 58.45M 17.04M 41.13%
Dec 31, 2022 41.42M 11.96M 40.58%
Dec 31, 2021 29.46M 11.25M 61.77%
Dec 31, 2020 18.21M 2.77M 17.91%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

TELA News

More News